This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Guideline

. 2001 Nov 14;286(18):2226-32.

doi: 10.1001/jama.286.18.2226.

From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001

No authors listed

PMID: 11757528
DOI: 10.1001/jama.286.18.2226

Guideline

From the Centers for Disease Control and Prevention. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001

No authors listed. JAMA. 2001.

. 2001 Nov 14;286(18):2226-32.

doi: 10.1001/jama.286.18.2226.

PMID: 11757528
DOI: 10.1001/jama.286.18.2226

No abstract available

PubMed Disclaimer

Similar articles

Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2001 Oct 26;50(42):909-19. MMWR Morb Mortal Wkly Rep. 2001. PMID: 11699843
From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
Centers for Disease Control and Prevention. Centers for Disease Control and Prevention. JAMA. 2001 Nov 21;286(19):2392-6. doi: 10.1001/jama.286.19.2392. JAMA. 2001. PMID: 11759667 No abstract available.
Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax.
Centers for Disease Control and Prevention (CDC). Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2001 Nov 2;50(43):941-8. MMWR Morb Mortal Wkly Rep. 2001. PMID: 11708591
Recognition and management of anthrax--an update.
Swartz MN. Swartz MN. N Engl J Med. 2001 Nov 29;345(22):1621-6. doi: 10.1056/NEJMra012892. Epub 2001 Nov 6. N Engl J Med. 2001. PMID: 11704686 Review. No abstract available.
Cutaneous anthrax: an overview.
Celia F. Celia F. Dermatol Nurs. 2002 Apr;14(2):89-92. Dermatol Nurs. 2002. PMID: 12017087 Review.

See all similar articles

Cited by

An overview of anthrax infection including the recently identified form of disease in injection drug users.
Hicks CW, Sweeney DA, Cui X, Li Y, Eichacker PQ. Hicks CW, et al. Intensive Care Med. 2012 Jul;38(7):1092-104. doi: 10.1007/s00134-012-2541-0. Epub 2012 Apr 24. Intensive Care Med. 2012. PMID: 22527064 Free PMC article. Review.
New target for inhibition of bacterial RNA polymerase: 'switch region'.
Srivastava A, Talaue M, Liu S, Degen D, Ebright RY, Sineva E, Chakraborty A, Druzhinin SY, Chatterjee S, Mukhopadhyay J, Ebright YW, Zozula A, Shen J, Sengupta S, Niedfeldt RR, Xin C, Kaneko T, Irschik H, Jansen R, Donadio S, Connell N, Ebright RH. Srivastava A, et al. Curr Opin Microbiol. 2011 Oct;14(5):532-43. doi: 10.1016/j.mib.2011.07.030. Epub 2011 Aug 19. Curr Opin Microbiol. 2011. PMID: 21862392 Free PMC article. Review.

Publication types

Actions

MeSH terms

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information